Envoy Medical (COCH) Net Cash Flow Growth (1y) (2022 - 2026)
Envoy Medical (COCH) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 76.43% |
| 10 | Envoy Medical | 46.20 Mn | 20.95 Mn | -274,000.00 | 12,254.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,254.24% |
| Dec 31, 2025 | -82.74% |
| Sep 30, 2025 | -164.58% |
| Jun 30, 2025 | 99.28% |
| Mar 31, 2025 | -124.31% |
| Dec 31, 2024 | 108.40% |
| Sep 30, 2024 | -84.03% |
| Jun 30, 2024 | -206.03% |
| Mar 31, 2024 | -21.72% |
| Dec 31, 2023 | -2,904.76% |
| Sep 30, 2023 | 2,637.12% |
| Jun 30, 2023 | -398.71% |
| Mar 31, 2023 | 4,189.71% |
| Dec 31, 2022 | 52.39% |
| Sep 30, 2022 | 6.54% |
| Jun 30, 2022 | 184.28% |
| Mar 31, 2022 | -101.07% |